INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
07/15/2026
Back to search
Official data from USPTO
ENTEROME
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ENTEROME
ST13
US500000079126292Class
1, 3, 5, 42
Filing
79126292
Registration
4561761
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
07/15/2026
Trademark type
Word
Nice classes
1, 3, 5, 42
Filing date
01/03/2013
Registration date
07/08/2014
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/22/2025
Last transaction
07/15/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
PARIS, FR
Examiner
TANNER, MICHAEL R
Current location
Historical data usage
Holders and representatives
Holders
ENTEROME
Representatives
THOMAS M. PALISI Lerner David LLP
Technical classification
Nice Classes
Class 1Class 3Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical and biochemical substances used for the manufacture and preservation of foodstuffsof pharmaceuticalcosmetic and veterinary productsprobiotic bacteria and probiotic bacterial cultures for use in the manufacture of food products and pharmaceutical preparationsprebiotic bacteria and prebiotic bacterial cultures for use in the manufacture of food products and pharmaceutical preparationsenzymes for use in the manufacture of food products and pharmaceutical preparations
Class 3
Cosmetic productscosmetic creams
Class 5
Pharmaceutical and medicinal products for human and veterinary usepharmaceutical preparations for treating metabolic disordersimmunological disorderscancerscentral nervous systems disordersgastroenterological disordersinfectious diseasesdiarrheaconstipation and irritable bowel syndrome; veterinary productsanti-infective products for veterinary useveterinary pharmaceutical preparations for treatment of metabolic disordersimmunological disorderscancerscentral nervous systems disordersgastroenterological disordersinfectious diseases and diarrhea; medicinal products for human and veterinary usenutritional supplements containing probiotic compositions; sanitary products for use in medicinesanitary sterilizing preparationsdisinfectants for sanitary purposessanitary preparations for medical use; dietetic food and substances for medical use in the nature of meal replacement products and prepackaged meal plansnutritional meal replacement bars adapted for medical use for treating metabolic disordersimmunological disorderscentral nervous systems disordersgastroenterological disordersinfectious diseasesdiarrheaconstipation and irritable bowel syndromepreparedprepackaged entrees for medical use for treating metabolic disordersimmunological disorderscentral nervous systems disordersgastroenterological disordersinfectious diseasesdiarrheaconstipation and irritable bowel syndromepreparedprepackaged snack foods for medical use for treating metabolic disordersimmunological disorderscentral nervous systems disordersgastroenterological disordersinfectious diseasesdiarrheaconstipation and irritable bowel syndromepreparedprepackaged yogurts for medical use for treating metabolic disordersimmunological disorderscentral nervous systems disordersgastroenterological disordersinfectious diseasesdiarrheaconstipation and irritable bowel syndromepreparedprepackaged desserts for medical use for treating metabolic disordersimmunological disorderscentral nervous systems disordersgastroenterological disordersinfectious diseasesdiarrheaconstipation and irritable bowel syndrome; nutritional supplements for medical use; food additives for medical usedietary fiber for treating metabolic disordersgastroenterological disordersdiarrheaconstipation and irritable bowel syndrome; nutritional food additives for medical purposes in the nature of natural food extracts derived from fishmeatvegetablesmicroorganisms and crops
Class 42
Human pharmaceutical research; research services provided by a pharmaceutical laboratoryproviding medical research testing services in the field of metabolic disordersimmunological disorderscentral nervous systems disordersgastroenterological disordersinfectious diseasesdiarrheaconstipationirritable bowel syndrome; Providing medical and scientific research information in the field of metabolic disordersimmunological disorderscentral nervous systems disordersgastroenterological disordersinfectious diseasesdiarrheaconstipationirritable bowel syndrome; providing medical and scientific research information in the field of pharmaceutical and clinical trials; scientific laboratory servicesgenetic testing of laboratory animals for pharmaceutical research purposes; biological research in the fields of microbiology and chemistry
Publications
History of USPTO decisions and trademark events.
43 publications found
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
12/22/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
04/22/2025
71AG
REGISTERED-SEC.71 ACCEPTED
04/22/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/21/2025
ES71
TEAS SECTION 71 RECEIVED
12/09/2024
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
07/08/2023
RNWL
INTERNATIONAL REGISTRATION RENEWED
01/26/2023
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
12/12/2021
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
11/04/2021
INPC
INVALIDATION PROCESSED
11/04/2021
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
10/10/2021
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
02/10/2021
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
02/10/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/10/2021
ES75
TEAS SECTION 71 & 15 RECEIVED
12/29/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/23/2015
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/04/2014
FIMP
FINAL DISPOSITION PROCESSED
12/04/2014
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/08/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
07/08/2014
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
05/30/2014
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
02/12/2014
PUBO
PUBLISHED FOR OPPOSITION
01/14/2014
GPNX
NOTIFICATION PROCESSED BY IB
01/11/2014
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/25/2013
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/25/2013
NPUB
NOTICE OF PUBLICATION
12/25/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/06/2013
ALIE
ASSIGNED TO LIE
12/02/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/07/2013
CNEA
EXAMINERS AMENDMENT MAILED
10/22/2013
XAEC
EXAMINER'S AMENDMENT ENTERED
10/22/2013
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/22/2013
RFNP
REFUSAL PROCESSED BY IB
05/15/2013
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/22/2013
RFRR
REFUSAL PROCESSED BY MPU
04/22/2013
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/20/2013
CNRT
NON-FINAL ACTION WRITTEN
04/19/2013
DOCK
ASSIGNED TO EXAMINER
04/17/2013
MAFR
APPLICATION FILING RECEIPT MAILED
03/15/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/11/2013
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/07/2013
Continuous trademark protection
Get notified about every new filing that threatens ENTEROME or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.